⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 17, 2026Journal of Personalized MedicineOpen Access

Bridging the Gap Between Pharmacogenomic Discovery and Clinical Implementation: Insights from Selected Studies on Inter-Individual Variability in Drug Response

View Full Paper

Ask AI

Bookmark

Share

Key Points

The research aims to address the challenge of inter-individual variability in drug response to enhance clinical application of pharmacogenomics.
Analysis of pharmacogenomic data from various studies
Assessment of drug efficacy and toxicity across different populations
Review of clinical implementation strategies
Identified significant inter-individual variability in drug responses
Demonstrated the necessity for personalized medicine approaches
Highlighted challenges in integrating pharmacogenomics into routine healthcare

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Selected studies reveal insights on drug response variability and its implications for clinical practice.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Su-Jun Lee (2026) studied this question.

synapsesocial.com/papers/69e473ff010ef96374d8fca0 https://doi.org/10.3390/jpm16040221

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Impact of Human Genome on Interindividual variability in Drug Response2024
2PHARMACOGENOMICS: BRIDGING THE GAP BETWEEN GENETICS AND DRUG THERAPYOriginal Research · 2026
3IMPACT OF PHARMACOGENOMICS IN PERSONALIZED MEDICINE: CURRENT APPLICATIONS AND FUTURE DIRECTIONSsystematic_review · 2026
4ROLE OF GENETIC VARIATION IN DRUG RESPONSEReview · 2026
5Transforming medicine through pharmacogenomics: Current status, challenges, and emerging horizonsReview · 2025